Find similar content

Source channel @githubtrending · Post #14723 · May 19

#go#anticensorship#dns#network#proxy#reality#shadowsocks#socks5#tls#trojan#tunnel#utls#vision#vless#vmess#vpn#wireguard#xhttp#xray#xtls#xudp Project X offers powerful network tools like Xray-core and REALITY, built on the efficient XTLS protocol that improves speed and security by reducing unnecessary encryption. It features advanced routing and fallback systems to keep your internet traffic safe and uninterrupted, ideal for streaming or video calls. The project is open-source under Mozilla Public License 2.0, encouraging community contributions to keep it evolving. You can easily install it on various platforms using official scripts, Docker, or one-click setups, and use many supported GUI clients on Windows, Linux, Android, iOS, and routers. This flexibility and strong security help you optimize and protect your network experience. https://github.com/XTLS/Xray-core

Hashtags

#go #anticensorship #dns #network #proxy #reality #shadowsocks #socks5 #tls #trojan #tunnel #utls #vision #vless #vmess #vpn #wireguard #xhttp #xray #xtls #xudp

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment